Fig. 9From: Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validationEnrichment plots by gene set enrichment analysis (GSEA). Relative pathways associated with the expression of CHRDL1 (a), SPARCL1 (b), SPP1 (c), and PENK (d) are illustratedBack to article page